These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 23953490)

  • 1. Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.
    Koch A; Weiskirchen R; Kunze J; Dückers H; Bruensing J; Buendgens L; Matthes M; Luedde T; Trautwein C; Tacke F
    J Crit Care; 2013 Dec; 28(6):947-53. PubMed ID: 23953490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
    Aydemir O; Ozcan B; Yucel H; Bas AY; Demirel N
    J Matern Fetal Neonatal Med; 2015 May; 28(8):977-82. PubMed ID: 24983667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
    Nijveldt RJ; Teerlink T; Van Der Hoven B; Siroen MP; Kuik DJ; Rauwerda JA; van Leeuwen PA
    Clin Nutr; 2003 Feb; 22(1):23-30. PubMed ID: 12553946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.
    Koch A; Weiskirchen R; Bruensing J; Dückers H; Buendgens L; Kunze J; Matthes M; Luedde T; Trautwein C; Tacke F
    Mediators Inflamm; 2013; 2013():413826. PubMed ID: 23935249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.
    Visser M; Vermeulen MA; Richir MC; Teerlink T; Houdijk AP; Kostense PJ; Wisselink W; de Mol BA; van Leeuwen PA; Oudemans-van Straaten HM
    Br J Nutr; 2012 May; 107(10):1458-65. PubMed ID: 22129964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of serum sclerostin concentrations in critically ill patients.
    Koch A; Weiskirchen R; Ludwig S; Buendgens L; Bruensing J; Yagmur E; Baeck C; Herbers U; Trautwein C; Tacke F
    J Crit Care; 2017 Feb; 37():38-44. PubMed ID: 27621111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.
    Koch A; Voigt S; Sanson E; Dückers H; Horn A; Zimmermann HW; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R45. PubMed ID: 21281508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine and critical illness.
    Brinkmann SJ; de Boer MC; Buijs N; van Leeuwen PA
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):90-7. PubMed ID: 24281375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment.
    Vucur M; Roderburg C; Kaiser L; Schneider AT; Roy S; Loosen SH; Luedde M; Trautwein C; Koch A; Tacke F; Luedde T
    Dis Markers; 2018; 2018():1983421. PubMed ID: 29606984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis.
    Buendgens L; Yagmur E; Bruensing J; Herbers U; Baeck C; Trautwein C; Koch A; Tacke F
    Dis Markers; 2017; 2017():5271203. PubMed ID: 29180833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.
    Richir MC; Ellger B; Teerlink T; Siroen MP; Visser M; Spreeuwenberg M; Girbes AR; van der Hoven B; van den Berghe G; Wilhelm AJ; de Vries TP; van Leeuwen PA
    Pharmacol Res; 2009 Dec; 60(6):519-24. PubMed ID: 19559792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
    Winkler MS; Nierhaus A; Rösler G; Lezius S; Harlandt O; Schwedhelm E; Böger RH; Kluge S
    Crit Care; 2018 Sep; 22(1):216. PubMed ID: 30231905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver plays a central role in asymmetric dimethylarginine-mediated organ injury.
    Ferrigno A; Di Pasqua LG; Berardo C; Richelmi P; Vairetti M
    World J Gastroenterol; 2015 May; 21(17):5131-7. PubMed ID: 25954086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.
    Koch A; Weiskirchen R; Sanson E; Zimmermann HW; Voigt S; Dückers H; Trautwein C; Tacke F
    Crit Care; 2010; 14(5):R179. PubMed ID: 20932285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis.
    Davis JS; Darcy CJ; Yeo TW; Jones C; McNeil YR; Stephens DP; Celermajer DS; Anstey NM
    PLoS One; 2011 Feb; 6(2):e17260. PubMed ID: 21364995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
    Koch A; Gressner OA; Sanson E; Tacke F; Trautwein C
    Crit Care; 2009; 13(3):R95. PubMed ID: 19545363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
    Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
    PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients.
    Tacke F; Roderburg C; Benz F; Cardenas DV; Luedde M; Hippe HJ; Frey N; Vucur M; Gautheron J; Koch A; Trautwein C; Luedde T
    Crit Care Med; 2014 May; 42(5):1096-104. PubMed ID: 24413579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.